Skip to main content

Currently Skimming:


Pages 65-70

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 65...
... The state of scientific knowledge from published research findings regarding the health and performance effects of numerous chemical substances that sometimes are ingested by commercial drivers; 2. Findings and practices relating to which psychoactive chemicals offer promise to commercial drivers striving to sustain alertness and to manage driver drowsiness or fatigue during partial sleep deprivation, which is so often necessitated by extended freight delivery operations; and 3.
From page 66...
... for commercial drivers who might benefit from using this more natural sleep promoter. Proper use of synthetic melatonin might be especially beneficial after completing night driving and when daytime sleep opportunities present themselves in over-the-road operations.
From page 67...
... It would be helpful to have an information packet that provides basic information about protocols for the use of caffeine, pointing out at least that as with any stimulant, the body adjusts to large intakes of caffeine, necessitating larger doses to obtain the same effect; that it takes about 20 min after consuming caffeine for the stimulation effects to kick-in; and that depending on the time of consumption before attempting to sleep, caffeine will affect sleep latency, quality, and restfulness. The differences in caffeine formulation (e.g., coffee, soft drinks, chewing gum, mints, and energy bars and drinks)
From page 68...
... The commercial advertising media has barraged the public with countless claims of the benefits of new energy drink products. The daily use of popularly sold energy drinks (e.g., Red Bull™, Monster Hitman™ shots, and a dozen others containing psychoactive substances)
From page 69...
... Medications typically used for neuropathy (gabapentin and pregabalin) were conditionally approved for more than three-quarters of respondents, based on detailed medical history or prescribing physician written statements (or both)
From page 70...
... As specified throughout the literature review, and highlighted in the conclusions, transportation researchers concerned with CMV safety issues can identify numerous areas where additional research may be called for regarding the chemical substances available to commercial drivers and that may impact driver performance and health.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.